Long before rice became the mainstay of Asia, prehistoric people in China turned to sago palm for starch. Chinese researchers reported this week in the online journal PLOS ONE that they had found ...

Biofund IV raised EUR 140 million in first closing of EUR 250 million fundBiofund IV to follow Kurma’s proven investment strategy and make 16 to 20 new investmentsFirst three investments of the ...

Kurma’s first couple of biofunds clocked in at 51 million euros and 55 million euros, respectively, before the firm ramped up the size of its Biofund III to 160 million euros ($177 million).

PARIS--(BUSINESS WIRE)--Kurma Partners announced the first closing of its Growth Opportunities fund at €160 million.Meeting the demand of the growing maturity of the European biotech and ...

About Kurma Partners Founded in July 2009 and based in Paris and Munich, Kurma Partners is a key European Venture Capital firm financing innovation in Healthcare and Biotechnology, from pre-seed ...

Paris-based Kurma has nearly €600m in AUM; This transaction follows Eurazeo’s majority stake acquisition in 2021; Since then, Eurazeo has committed nearly €100m to its funds; ...